Japan Argatroban Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

    This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Argatroban market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Argatroban market. Detailed analysis of key players, along with key growth strategies adopted by Argatroban industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GlaxoSmithKline

    • Eagle Pharmaceuticals

    • WEST-WARD

    • Teva Pharmaceutical Industries

    • Mitsubishi Tanabe Pharma

    • Pfizer

    • SANDOZ

    • fresenius-kabi

    By Type:

    • Argatroban Powder

    • Argatroban Injection

    By End-User:

    • Heparin-induced thrombocytopenia (HIT)

    • Percutaneous Coronary Intervention

    • Cerebral arterial thrombosis

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Argatroban Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Argatroban Market Size and Growth Rate of Argatroban Powder from 2014 to 2026

      • 1.3.2 Japan Argatroban Market Size and Growth Rate of Argatroban Injection from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT)

      • 1.4.2 Market Size and Growth Rate of Percutaneous Coronary Intervention

      • 1.4.3 Market Size and Growth Rate of Cerebral arterial thrombosis

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Argatroban Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Argatroban by Major Types

      • 3.4.1 Japan Argatroban Market Size and Growth Rate of Argatroban Powder from 2014 to 2026

      • 3.4.2 Japan Argatroban Market Size and Growth Rate of Argatroban Injection from 2014 to 2026

    4 Segmentation of Argatroban Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Argatroban by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Argatroban in Heparin-induced thrombocytopenia (HIT)

      • 4.4.2 Market Size and Growth Rate of Argatroban in Percutaneous Coronary Intervention

      • 4.4.3 Market Size and Growth Rate of Argatroban in Cerebral arterial thrombosis

    5 Market Analysis by Regions

    • 5.1 Japan Argatroban Production Analysis by Regions

    • 5.2 Japan Argatroban Consumption Analysis by Regions

    6 Hokkaido Argatroban Landscape Analysis

    • 6.1 Hokkaido Argatroban Landscape Analysis by Major Types

    • 6.2 Hokkaido Argatroban Landscape Analysis by Major End-Users

    7 Tohoku Argatroban Landscape Analysis

    • 7.1 Tohoku Argatroban Landscape Analysis by Major Types

    • 7.2 Tohoku Argatroban Landscape Analysis by Major End-Users

    8 Kanto Argatroban Landscape Analysis

    • 8.1 Kanto Argatroban Landscape Analysis by Major Types

    • 8.2 Kanto Argatroban Landscape Analysis by Major End-Users

    9 Chubu Argatroban Landscape Analysis

    • 9.1 Chubu Argatroban Landscape Analysis by Major Types

    • 9.2 Chubu Argatroban Landscape Analysis by Major End-Users

    10 Kinki Argatroban Landscape Analysis

    • 10.1 Kinki Argatroban Landscape Analysis by Major Types

    • 10.2 Kinki Argatroban Landscape Analysis by Major End-Users

    11 Chugoku Argatroban Landscape Analysis

    • 11.1 Chugoku Argatroban Landscape Analysis by Major Types

    • 11.2 Chugoku Argatroban Landscape Analysis by Major End-Users

    12 Shikoku Argatroban Landscape Analysis

    • 12.1 Shikoku Argatroban Landscape Analysis by Major Types

    • 12.2 Shikoku Argatroban Landscape Analysis by Major End-Users

    13 Kyushu Argatroban Landscape Analysis

    • 13.1 Kyushu Argatroban Landscape Analysis by Major Types

    • 13.2 Kyushu Argatroban Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.1.2 GlaxoSmithKline Market Performance

      • 14.1.3 GlaxoSmithKline Product and Service Introduction

    • 14.2 Eagle Pharmaceuticals

      • 14.2.1 Eagle Pharmaceuticals Company Profile and Recent Development

      • 14.2.2 Eagle Pharmaceuticals Market Performance

      • 14.2.3 Eagle Pharmaceuticals Product and Service Introduction

    • 14.3 WEST-WARD

      • 14.3.1 WEST-WARD Company Profile and Recent Development

      • 14.3.2 WEST-WARD Market Performance

      • 14.3.3 WEST-WARD Product and Service Introduction

    • 14.4 Teva Pharmaceutical Industries

      • 14.4.1 Teva Pharmaceutical Industries Company Profile and Recent Development

      • 14.4.2 Teva Pharmaceutical Industries Market Performance

      • 14.4.3 Teva Pharmaceutical Industries Product and Service Introduction

    • 14.5 Mitsubishi Tanabe Pharma

      • 14.5.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

      • 14.5.2 Mitsubishi Tanabe Pharma Market Performance

      • 14.5.3 Mitsubishi Tanabe Pharma Product and Service Introduction

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Profile and Recent Development

      • 14.6.2 Pfizer Market Performance

      • 14.6.3 Pfizer Product and Service Introduction

    • 14.7 SANDOZ

      • 14.7.1 SANDOZ Company Profile and Recent Development

      • 14.7.2 SANDOZ Market Performance

      • 14.7.3 SANDOZ Product and Service Introduction

    • 14.8 fresenius-kabi

      • 14.8.1 fresenius-kabi Company Profile and Recent Development

      • 14.8.2 fresenius-kabi Market Performance

      • 14.8.3 fresenius-kabi Product and Service Introduction

     

    The List of Tables and Figures (Totals 103 Figures and 195 Tables)

    • Figure Japan Argatroban Market Size and Growth Rate of Argatroban Powder from 2014 to 2026

    • Figure Japan Argatroban Market Size and Growth Rate of Argatroban Injection from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT)

    • Figure Market Size and Growth Rate of Percutaneous Coronary Intervention

    • Figure Market Size and Growth Rate of Cerebral arterial thrombosis

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Argatroban Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Argatroban Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Argatroban

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Argatroban by Different Types from 2014 to 2026

    • Table Consumption Share of Argatroban by Different Types from 2014 to 2026

    • Figure Japan Argatroban Market Size and Growth Rate of Argatroban Powder from 2014 to 2026

    • Figure Japan Argatroban Market Size and Growth Rate of Argatroban Injection from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Argatroban by Different End-Users from 2014 to 2026

    • Table Consumption Share of Argatroban by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Heparin-induced thrombocytopenia (HIT)

    • Figure Market Size and Growth Rate of Percutaneous Coronary Intervention

    • Figure Market Size and Growth Rate of Cerebral arterial thrombosis

    • Table Japan Argatroban Production by Regions

    • Table Japan Argatroban Production Share by Regions

    • Figure Japan Argatroban Production Share by Regions in 2014

    • Figure Japan Argatroban Production Share by Regions in 2018

    • Figure Japan Argatroban Production Share by Regions in 2026

    • Table Japan Argatroban Consumption by Regions

    • Table Japan Argatroban Consumption Share by Regions

    • Figure Japan Argatroban Consumption Share by Regions in 2014

    • Figure Japan Argatroban Consumption Share by Regions in 2018

    • Figure Japan Argatroban Consumption Share by Regions in 2026

    • Table Hokkaido Argatroban Consumption by Types from 2014 to 2026

    • Table Hokkaido Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Argatroban Consumption Share by Types in 2014

    • Figure Hokkaido Argatroban Consumption Share by Types in 2018

    • Figure Hokkaido Argatroban Consumption Share by Types in 2026

    • Table Hokkaido Argatroban Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Argatroban Consumption Share by End-Users in 2014

    • Figure Hokkaido Argatroban Consumption Share by End-Users in 2018

    • Figure Hokkaido Argatroban Consumption Share by End-Users in 2026

    • Table Tohoku Argatroban Consumption by Types from 2014 to 2026

    • Table Tohoku Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Argatroban Consumption Share by Types in 2014

    • Figure Tohoku Argatroban Consumption Share by Types in 2018

    • Figure Tohoku Argatroban Consumption Share by Types in 2026

    • Table Tohoku Argatroban Consumption by End-Users from 2014 to 2026

    • Table Tohoku Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Argatroban Consumption Share by End-Users in 2014

    • Figure Tohoku Argatroban Consumption Share by End-Users in 2018

    • Figure Tohoku Argatroban Consumption Share by End-Users in 2026

    • Table Kanto Argatroban Consumption by Types from 2014 to 2026

    • Table Kanto Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Kanto Argatroban Consumption Share by Types in 2014

    • Figure Kanto Argatroban Consumption Share by Types in 2018

    • Figure Kanto Argatroban Consumption Share by Types in 2026

    • Table Kanto Argatroban Consumption by End-Users from 2014 to 2026

    • Table Kanto Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Argatroban Consumption Share by End-Users in 2014

    • Figure Kanto Argatroban Consumption Share by End-Users in 2018

    • Figure Kanto Argatroban Consumption Share by End-Users in 2026

    • Table Chubu Argatroban Consumption by Types from 2014 to 2026

    • Table Chubu Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Chubu Argatroban Consumption Share by Types in 2014

    • Figure Chubu Argatroban Consumption Share by Types in 2018

    • Figure Chubu Argatroban Consumption Share by Types in 2026

    • Table Chubu Argatroban Consumption by End-Users from 2014 to 2026

    • Table Chubu Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Argatroban Consumption Share by End-Users in 2014

    • Figure Chubu Argatroban Consumption Share by End-Users in 2018

    • Figure Chubu Argatroban Consumption Share by End-Users in 2026

    • Table Kinki Argatroban Consumption by Types from 2014 to 2026

    • Table Kinki Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Kinki Argatroban Consumption Share by Types in 2014

    • Figure Kinki Argatroban Consumption Share by Types in 2018

    • Figure Kinki Argatroban Consumption Share by Types in 2026

    • Table Kinki Argatroban Consumption by End-Users from 2014 to 2026

    • Table Kinki Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Argatroban Consumption Share by End-Users in 2014

    • Figure Kinki Argatroban Consumption Share by End-Users in 2018

    • Figure Kinki Argatroban Consumption Share by End-Users in 2026

    • Table Chugoku Argatroban Consumption by Types from 2014 to 2026

    • Table Chugoku Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Argatroban Consumption Share by Types in 2014

    • Figure Chugoku Argatroban Consumption Share by Types in 2018

    • Figure Chugoku Argatroban Consumption Share by Types in 2026

    • Table Chugoku Argatroban Consumption by End-Users from 2014 to 2026

    • Table Chugoku Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Argatroban Consumption Share by End-Users in 2014

    • Figure Chugoku Argatroban Consumption Share by End-Users in 2018

    • Figure Chugoku Argatroban Consumption Share by End-Users in 2026

    • Table Shikoku Argatroban Consumption by Types from 2014 to 2026

    • Table Shikoku Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Argatroban Consumption Share by Types in 2014

    • Figure Shikoku Argatroban Consumption Share by Types in 2018

    • Figure Shikoku Argatroban Consumption Share by Types in 2026

    • Table Shikoku Argatroban Consumption by End-Users from 2014 to 2026

    • Table Shikoku Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Argatroban Consumption Share by End-Users in 2014

    • Figure Shikoku Argatroban Consumption Share by End-Users in 2018

    • Figure Shikoku Argatroban Consumption Share by End-Users in 2026

    • Table Kyushu Argatroban Consumption by Types from 2014 to 2026

    • Table Kyushu Argatroban Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Argatroban Consumption Share by Types in 2014

    • Figure Kyushu Argatroban Consumption Share by Types in 2018

    • Figure Kyushu Argatroban Consumption Share by Types in 2026

    • Table Kyushu Argatroban Consumption by End-Users from 2014 to 2026

    • Table Kyushu Argatroban Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Argatroban Consumption Share by End-Users in 2014

    • Figure Kyushu Argatroban Consumption Share by End-Users in 2018

    • Figure Kyushu Argatroban Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Eagle Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eagle Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Eagle Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Eagle Pharmaceuticals

    • Table Product and Service Introduction of Eagle Pharmaceuticals

    • Table Company Profile and Development Status of WEST-WARD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WEST-WARD

    • Figure Sales and Growth Rate Analysis of WEST-WARD

    • Figure Revenue and Market Share Analysis of WEST-WARD

    • Table Product and Service Introduction of WEST-WARD

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of SANDOZ

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SANDOZ

    • Figure Sales and Growth Rate Analysis of SANDOZ

    • Figure Revenue and Market Share Analysis of SANDOZ

    • Table Product and Service Introduction of SANDOZ

    • Table Company Profile and Development Status of fresenius-kabi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of fresenius-kabi

    • Figure Sales and Growth Rate Analysis of fresenius-kabi

    • Figure Revenue and Market Share Analysis of fresenius-kabi

    • Table Product and Service Introduction of fresenius-kabi

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.